BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20042725)

  • 1. Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells.
    Ophir E; Eidelstein Y; Afik R; Bachar-Lustig E; Reisner Y
    Blood; 2010 Mar; 115(10):2095-104. PubMed ID: 20042725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.
    Ophir E; Or-Geva N; Gurevich I; Tal O; Eidelstein Y; Shezen E; Margalit R; Lask A; Shakhar G; Hagin D; Bachar-Lustig E; Reich-Zeliger S; Beilhack A; Negrin R; Reisner Y
    Blood; 2013 Feb; 121(7):1220-8. PubMed ID: 23223359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotype.
    Ophir E; Eidelstein Y; Bachar-Lustig E; Hagin D; Or-Geva N; Lask A; Reisner Y
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):393-401. PubMed ID: 21925092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells.
    Lask A; Ophir E; Or-Geva N; Cohen-Fredarow A; Afik R; Eidelstein Y; Reich-Zeliger S; Nathansohn B; Edinger M; Negrin RS; Hagin D; Reisner Y
    Blood; 2013 Apr; 121(15):3033-40. PubMed ID: 23446736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
    Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
    J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells.
    Reich-Zeliger S; Bachar-Lustig E; Bar-Ilan A; Reisner Y
    J Immunol; 2007 Nov; 179(10):6389-94. PubMed ID: 17982025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
    Bhattacharyya S; Chawla A; Smith K; Zhou Y; Talib S; Wardwell B; Cowan MJ
    J Immunol; 2002 Dec; 169(11):6133-40. PubMed ID: 12444116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.
    Or-Geva N; Reisner Y
    Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S14-20. PubMed ID: 26039201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction by third-party "off-the-shelf" CD4+CD25+ Treg cells.
    Steiner D; Brunicki N; Blazar BR; Bachar-Lustig E; Reisner Y
    Exp Hematol; 2006 Jan; 34(1):66-71. PubMed ID: 16413392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.
    Bachar-Lustig E; Reich-Zeliger S; Reisner Y
    Blood; 2003 Sep; 102(6):1943-50. PubMed ID: 12775573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.
    Fehr T; Wang S; Haspot F; Kurtz J; Blaha P; Hogan T; Chittenden M; Wekerle T; Sykes M
    J Immunol; 2008 Sep; 181(6):4371-80. PubMed ID: 18768896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.